Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Bladé

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
Best Practice & Research. Clinical Haematology|July 20, 2005
Renal, hematologic and infectious complications in multiple myelomaJoan Bladé, Laura Rosiñol
Current Opinion in Oncology|October 9, 2008
Advances in therapy of multiple myelomaJoan Bladé, Laura Rosiñol
Current Treatment Options in Oncology|April 18, 2006
Smoldering multiple myeloma and monoclonal gammopathy of undetermined significanceJoan Bladé, Laura Rosiñol
Hematology/Oncology Clinics of North America|November 13, 2007
Complications of multiple myelomaJoan Bladé, Laura Rosiñol
Expert Review of Hematology|February 4, 2014
The comprehensive clinical management of multiple myeloma and related-plasma cell disordersPaul G Richardson, Joan Bladé
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Bortezomib: a valuable new antineoplastic strategy in multiple myelomaJoan Bladé, M Teresa Cibeira, Laura Rosiñol
Advances in Chronic Kidney Disease|August 28, 2012
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspectiveEsftathios Kastritis, Meletios A Dimopoulos, Joan Bladé
Blood|January 15, 2015
How I treat relapsed myelomaJoan Bladé, Laura Rosiñol, Carlos Fernández de Larrea
Seminars in Oncology|April 30, 2003
Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?Joan Bladé, Silvia Montoto, Laura Rosiñol, et al.
Ejhaem|February 26, 2024
A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow-upLarry D Anderson, Joan Bladé, Robert A Kyle
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
Best Practice & Research. Clinical Haematology|July 20, 2005
Renal, hematologic and infectious complications in multiple myelomaJoan Bladé, Laura Rosiñol
Current Opinion in Oncology|October 9, 2008
Advances in therapy of multiple myelomaJoan Bladé, Laura Rosiñol
Current Treatment Options in Oncology|April 18, 2006
Smoldering multiple myeloma and monoclonal gammopathy of undetermined significanceJoan Bladé, Laura Rosiñol
Hematology/Oncology Clinics of North America|November 13, 2007
Complications of multiple myelomaJoan Bladé, Laura Rosiñol
Expert Review of Hematology|February 4, 2014
The comprehensive clinical management of multiple myeloma and related-plasma cell disordersPaul G Richardson, Joan Bladé
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Bortezomib: a valuable new antineoplastic strategy in multiple myelomaJoan Bladé, M Teresa Cibeira, Laura Rosiñol
Advances in Chronic Kidney Disease|August 28, 2012
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspectiveEsftathios Kastritis, Meletios A Dimopoulos, Joan Bladé
Blood|January 15, 2015
How I treat relapsed myelomaJoan Bladé, Laura Rosiñol, Carlos Fernández de Larrea
Seminars in Oncology|April 30, 2003
Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?Joan Bladé, Silvia Montoto, Laura Rosiñol, et al.
Ejhaem|February 26, 2024
A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow-upLarry D Anderson, Joan Bladé, Robert A Kyle
Pageof 24